Interactions between vitamins and dietary phytoestrogens in the treatment of prostatic disease.

T.A. Winters, S. Adler, W.J. Banz, and N.R. Henry


Funded by a
Vitamin Anti-trust Settlement Grant,
Illinois Office of the Attorney General


Progress Report:     Year 2, 3rd Quarter (May 2004)

Laboratory and statistical analyses continue on the studies described under objectives 1 and 2. Under objective 2, a series of studies have been completed to determine the effects of vitamins and isoflavones alone and in combination on cell proliferation as measured by thymidine incorporation. In this study, the isoflavones genistein, glycitein, and daidzein at 10 uM alone all inhibit growth of PC-3 prostate cancer cells by 64, 36, and 37%, respectively. Vitamins E, A, and D inhibited PC-3 cell growth by 95, 64, and 98%, respectively. Vitamin E in combination with genistein further inhibited growth another 2% over Vitamin E alone. Vitamin D treatment exhibited some negligible additive decreases in combination with genistein and glycitein. We are awaiting final approval from the Institutional Animal Care and Use Committee to perform the immunosuppressed mouse study described under objective 3. The first study will examine the effects of vitamin E alone and in combination with a diet high in soy isoflavones will be performed first based on our in vitro studies of Objective 2. Under Objective 4, we are beginning Real Time-PCR studies of how dietary vitamins and phytoestrogens effect the expression of the peroxisome proliferator-activated receptor (PPAR) a potential component of the transcriptional machinery regulated by these bioactive compounds. Our research groups have found in another system that soy diets rich in isoflavones regulate PPAR expression.

Research from this project was also highlighted in an article in "Perspectives" magazine on Cancer Research at SIUC (See "inner workings").

 












~~~~~Revised 7/21/04~~~~~ TAW